Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 9 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005930 | axoneme | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
GO:0001534 | radial spoke | 2 | 2 |
GO:0032991 | protein-containing complex | 1 | 2 |
Related structures:
AlphaFold database: A4H541
Term | Name | Level | Count |
---|---|---|---|
GO:0000226 | microtubule cytoskeleton organization | 3 | 1 |
GO:0001578 | microtubule bundle formation | 4 | 1 |
GO:0003341 | cilium movement | 4 | 3 |
GO:0006996 | organelle organization | 4 | 3 |
GO:0007010 | cytoskeleton organization | 5 | 1 |
GO:0007017 | microtubule-based process | 2 | 3 |
GO:0007018 | microtubule-based movement | 3 | 3 |
GO:0009987 | cellular process | 1 | 3 |
GO:0016043 | cellular component organization | 3 | 3 |
GO:0022607 | cellular component assembly | 4 | 3 |
GO:0030030 | cell projection organization | 4 | 3 |
GO:0030031 | cell projection assembly | 5 | 3 |
GO:0035082 | axoneme assembly | 5 | 1 |
GO:0044458 | motile cilium assembly | 7 | 1 |
GO:0044782 | cilium organization | 5 | 3 |
GO:0060271 | cilium assembly | 6 | 3 |
GO:0060294 | cilium movement involved in cell motility | 5 | 3 |
GO:0070925 | organelle assembly | 5 | 3 |
GO:0071840 | cellular component organization or biogenesis | 2 | 3 |
GO:0120031 | plasma membrane bounded cell projection assembly | 6 | 3 |
GO:0120036 | plasma membrane bounded cell projection organization | 5 | 3 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 163 | 167 | PF00656 | 0.498 |
CLV_NRD_NRD_1 | 173 | 175 | PF00675 | 0.629 |
CLV_PCSK_KEX2_1 | 175 | 177 | PF00082 | 0.520 |
CLV_PCSK_PC1ET2_1 | 175 | 177 | PF00082 | 0.520 |
CLV_PCSK_SKI1_1 | 176 | 180 | PF00082 | 0.655 |
CLV_PCSK_SKI1_1 | 207 | 211 | PF00082 | 0.498 |
CLV_PCSK_SKI1_1 | 292 | 296 | PF00082 | 0.439 |
DEG_SCF_FBW7_1 | 125 | 131 | PF00400 | 0.414 |
DOC_CKS1_1 | 125 | 130 | PF01111 | 0.555 |
DOC_MAPK_gen_1 | 174 | 185 | PF00069 | 0.444 |
DOC_MAPK_gen_1 | 34 | 42 | PF00069 | 0.457 |
DOC_USP7_MATH_1 | 66 | 70 | PF00917 | 0.449 |
DOC_USP7_UBL2_3 | 175 | 179 | PF12436 | 0.493 |
DOC_WW_Pin1_4 | 124 | 129 | PF00397 | 0.591 |
DOC_WW_Pin1_4 | 35 | 40 | PF00397 | 0.445 |
LIG_14-3-3_CanoR_1 | 174 | 183 | PF00244 | 0.595 |
LIG_14-3-3_CanoR_1 | 221 | 226 | PF00244 | 0.535 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.352 |
LIG_FHA_1 | 261 | 267 | PF00498 | 0.385 |
LIG_FHA_1 | 283 | 289 | PF00498 | 0.386 |
LIG_FHA_2 | 125 | 131 | PF00498 | 0.476 |
LIG_FHA_2 | 15 | 21 | PF00498 | 0.495 |
LIG_LIR_Apic_2 | 263 | 268 | PF02991 | 0.460 |
LIG_LIR_Apic_2 | 299 | 305 | PF02991 | 0.323 |
LIG_LIR_Gen_1 | 237 | 245 | PF02991 | 0.334 |
LIG_LIR_Gen_1 | 78 | 85 | PF02991 | 0.543 |
LIG_LIR_Nem_3 | 177 | 183 | PF02991 | 0.368 |
LIG_LIR_Nem_3 | 51 | 56 | PF02991 | 0.337 |
LIG_LIR_Nem_3 | 69 | 73 | PF02991 | 0.374 |
LIG_LIR_Nem_3 | 78 | 82 | PF02991 | 0.409 |
LIG_Pex14_1 | 278 | 282 | PF04695 | 0.323 |
LIG_Pex14_2 | 322 | 326 | PF04695 | 0.411 |
LIG_PTB_Apo_2 | 2 | 9 | PF02174 | 0.420 |
LIG_PTB_Apo_2 | 219 | 226 | PF02174 | 0.385 |
LIG_PTB_Apo_2 | 290 | 297 | PF02174 | 0.311 |
LIG_PTB_Apo_2 | 58 | 65 | PF02174 | 0.502 |
LIG_PTB_Phospho_1 | 2 | 8 | PF10480 | 0.426 |
LIG_PTB_Phospho_1 | 290 | 296 | PF10480 | 0.349 |
LIG_SH2_CRK | 100 | 104 | PF00017 | 0.417 |
LIG_SH2_STAP1 | 106 | 110 | PF00017 | 0.490 |
LIG_SH2_STAT5 | 239 | 242 | PF00017 | 0.313 |
LIG_SH2_STAT5 | 265 | 268 | PF00017 | 0.479 |
LIG_SH2_STAT5 | 314 | 317 | PF00017 | 0.333 |
LIG_SH2_STAT5 | 8 | 11 | PF00017 | 0.475 |
LIG_SH3_3 | 120 | 126 | PF00018 | 0.582 |
LIG_SH3_3 | 165 | 171 | PF00018 | 0.624 |
LIG_SH3_5 | 261 | 265 | PF00018 | 0.479 |
LIG_SUMO_SIM_par_1 | 181 | 187 | PF11976 | 0.391 |
LIG_TRAF2_1 | 158 | 161 | PF00917 | 0.720 |
LIG_TYR_ITSM | 49 | 56 | PF00017 | 0.240 |
MOD_CK1_1 | 14 | 20 | PF00069 | 0.492 |
MOD_CK1_1 | 69 | 75 | PF00069 | 0.388 |
MOD_CK1_1 | 83 | 89 | PF00069 | 0.458 |
MOD_CK2_1 | 14 | 20 | PF00069 | 0.353 |
MOD_CK2_1 | 155 | 161 | PF00069 | 0.750 |
MOD_CK2_1 | 181 | 187 | PF00069 | 0.450 |
MOD_GlcNHglycan | 316 | 319 | PF01048 | 0.436 |
MOD_GlcNHglycan | 82 | 85 | PF01048 | 0.295 |
MOD_GSK3_1 | 124 | 131 | PF00069 | 0.602 |
MOD_GSK3_1 | 44 | 51 | PF00069 | 0.451 |
MOD_GSK3_1 | 7 | 14 | PF00069 | 0.342 |
MOD_LATS_1 | 232 | 238 | PF00433 | 0.362 |
MOD_N-GLC_1 | 11 | 16 | PF02516 | 0.267 |
MOD_N-GLC_1 | 221 | 226 | PF02516 | 0.512 |
MOD_N-GLC_1 | 282 | 287 | PF02516 | 0.426 |
MOD_NEK2_1 | 11 | 16 | PF00069 | 0.454 |
MOD_NEK2_1 | 24 | 29 | PF00069 | 0.289 |
MOD_NEK2_1 | 326 | 331 | PF00069 | 0.327 |
MOD_NEK2_2 | 128 | 133 | PF00069 | 0.395 |
MOD_NEK2_2 | 276 | 281 | PF00069 | 0.467 |
MOD_NEK2_2 | 296 | 301 | PF00069 | 0.384 |
MOD_NEK2_2 | 66 | 71 | PF00069 | 0.444 |
MOD_PIKK_1 | 29 | 35 | PF00454 | 0.505 |
MOD_PK_1 | 181 | 187 | PF00069 | 0.498 |
MOD_PKA_1 | 174 | 180 | PF00069 | 0.380 |
MOD_PKA_1 | 234 | 240 | PF00069 | 0.469 |
MOD_PKA_2 | 220 | 226 | PF00069 | 0.534 |
MOD_Plk_1 | 128 | 134 | PF00069 | 0.565 |
MOD_Plk_1 | 19 | 25 | PF00069 | 0.435 |
MOD_Plk_1 | 221 | 227 | PF00069 | 0.546 |
MOD_Plk_2-3 | 155 | 161 | PF00069 | 0.619 |
MOD_Plk_4 | 296 | 302 | PF00069 | 0.318 |
MOD_Plk_4 | 66 | 72 | PF00069 | 0.418 |
MOD_ProDKin_1 | 124 | 130 | PF00069 | 0.587 |
MOD_ProDKin_1 | 35 | 41 | PF00069 | 0.443 |
TRG_DiLeu_BaEn_4 | 87 | 93 | PF01217 | 0.451 |
TRG_DiLeu_BaLyEn_6 | 26 | 31 | PF01217 | 0.363 |
TRG_ENDOCYTIC_2 | 100 | 103 | PF00928 | 0.502 |
TRG_ENDOCYTIC_2 | 239 | 242 | PF00928 | 0.306 |
TRG_ENDOCYTIC_2 | 53 | 56 | PF00928 | 0.322 |
TRG_ENDOCYTIC_2 | 8 | 11 | PF00928 | 0.487 |
TRG_ER_diArg_1 | 108 | 111 | PF00400 | 0.350 |
TRG_ER_diArg_1 | 173 | 176 | PF00400 | 0.569 |
TRG_ER_diArg_1 | 250 | 253 | PF00400 | 0.395 |
TRG_NLS_MonoExtN_4 | 171 | 178 | PF00514 | 0.508 |
TRG_Pf-PMV_PEXEL_1 | 292 | 297 | PF00026 | 0.446 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P8E1 | Leptomonas seymouri | 26% | 100% |
A0A0N1IL99 | Leptomonas seymouri | 71% | 98% |
A0A0S4J8G1 | Bodo saltans | 40% | 100% |
A0A1X0NQ76 | Trypanosomatidae | 48% | 100% |
A0A1X0P3V0 | Trypanosomatidae | 26% | 100% |
A0A3Q8IKD9 | Leishmania donovani | 24% | 100% |
A0A3R7MSU5 | Trypanosoma rangeli | 48% | 99% |
A0A3S7WQ16 | Leishmania donovani | 86% | 100% |
A0A422P0B0 | Trypanosoma rangeli | 26% | 100% |
A4HLW1 | Leishmania braziliensis | 22% | 100% |
A4HTB7 | Leishmania infantum | 85% | 99% |
C9ZUK2 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 48% | 100% |
D0A660 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 28% | 100% |
E9AHR8 | Leishmania infantum | 24% | 100% |
E9ALB0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 85% | 100% |
E9B489 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 24% | 100% |
Q4Q3T7 | Leishmania major | 25% | 90% |
Q4QIJ4 | Leishmania major | 86% | 100% |
Q5TYW6 | Danio rerio | 27% | 100% |
Q6DFN5 | Xenopus tropicalis | 24% | 100% |
Q9D9V4 | Mus musculus | 25% | 100% |
Q9H1X1 | Homo sapiens | 24% | 100% |
V5B8M6 | Trypanosoma cruzi | 27% | 100% |